We examined the effects of osteocyte secreted factors on myogenesis and muscle function. MLO-Y4 osteocyte-like cell conditioned media (CM) (10%) increased ex vivo soleus muscle contractile force by ~25%. MLO-Y4 and primary osteocyte CM (1-10%) stimulated myogenic differentiation of C2C12 myoblasts, but 10% osteoblast CMs did not enhance C2C12 cell differentiation. Since 
Introduction
Muscle and bone are connected both anatomically and functionally and interact as a functional unit (1) . Musculoskeletal diseases are the most common cause of chronic disabilities worldwide. Osteoporosis/osteopenia (loss of bone tissue and function) and sarcopenia (progressive muscle loss with a greater and disproportional loss of muscle force/strength) are inevitable consequences of the aging process and prevalent in the frail elderly and have become a growing public health concern (2) .
The emerging field of bone-muscle crosstalk is helping to clarify the role of bones and muscles as endocrine organs because they produce and secrete "hormone-like factors" that can mutually influence each other and other tissues (3, 4) . Recently, evidence has emerged that osteocytes secrete factors that have profound effects on C2C12 muscle cells in culture, and vice versa (3, 5) , suggesting that muscle and bone communicate at a molecular level via biochemical factors that are reciprocally important for optimal function (6) .
Bones secrete a host of factors that have clear paracrine and endocrine effects, such as FGF23, Sclerostin, Osteocalcin, WNTs, Prostaglandin E2 (PGE2), etc. (reviewed in (7) ).
Sclerostin is one of these factors, which has gained much attention because of recent clinical applications and trials (8) . Sclerostin is one of the osteocyte-specific proteins, and is product of the SOST gene (9) , which is expressed by mature osteocytes (10, 11) . Sclerostin is a negative regulator of Wnt/β-catenin signaling pathway by binding to the Wnt coreceptors, low-density lipoprotein receptor-related proteins 5 and 6 (LRP5 and LRP6) (12) . In the presence of Sclerostin, Wnt-receptor interaction is inhibited, and β-catenin is phosphorylated by glycogen synthase kinase 3 and targeted for ubiquitination and degradation via the proteosome pathway (13) .
Studies using loss of function and gain of function mouse models of Sost have demonstrated increased
This article is protected by copyright. All rights reserved and decreased bone mass, respectively (10) . Our earlier studies demonstrated that many of the effects of bone cell conditioned medium in triggering acceleration of myogenesis could be partially mimicked by low nanomolar range concentrations of PGE2 (3) .
The Wnt /β-catenin signaling pathway is important for cell and tissue homeostasis, since secreted WNTs act through specific receptors to control and modulate cell proliferation, differentiation, apoptosis, survival, migration, and polarity (reviewed in (14) ). They play critical roles during embryonic development (including muscle and skeletal patterning) as well as in postnatal health and diseases, including cancer and degenerative disorders. The Wnt/β-catenin signal pathway has been shown to be an important component of bone mass accrual, regulation and maintenance (15) , and accumulating data show that the Wnt/β-catenin signal pathway is strongly implicated in the skeletal muscle development, growth and regeneration (16) .
To determine whether osteocytes can potentially regulate muscle function, we tested the effects of MLO-Y4 conditioned medium (MLO-Y4 CM) on muscle contractility in soleus (SOL) muscles using a murine ex vivo muscle contractility assay and found out that MLO-Y4 CM increased the contractile force of SOL muscles. To gain new insight into the mechanisms of bone to muscle signaling we have used MLO-Y4 osteocyte-like cells, osteoblast cells, primary osteocytes and C2C12 myoblasts as in vitro models. We report that MLO-Y4 cells and primary osteocytes secrete factors that potently stimulate myogenesis, accompanied by enhanced β-catenin translocation, suggesting that the effect may be mediated via Wnt/β-catenin signaling.
However, 10% osteoblast CMs did not enhance C2C12 cell differentiation. We therefore investigated the expression of Wnts in osteocytes and showed that WNT3a, which is expressed in osteocytes, mirrored the effects of osteocyte conditioned medium on myogenesis. Knocking down Wnt3a in MLO-Y4 osteocytes inhibited the effect of CM on C2C12 myogenic differentiation. Sclerostin inhibited the effects of CM or WNT3a on C2C12 cell differentiation.
To determine potential mechanisms of contractile force enhancement, we examined the effects of osteocyte conditioned medium on calcium release from the sarcoplasmic reticulum (SR). Our in vitro and ex vivo data show that osteocytes secrete soluble factors that enhance myogenic differentiation, enhance both contractile force and calcium release from the SR, and provide evidence that WNT3a is a potential factor from osteocytes with the intrinsic potential to modulate these effects of bone-muscle crosstalk.
Materials and methods

Materials
DMEM high glucose media, αMEM media, penicillin-streptomycin (P/S) 10,000 U/mL each and (5) . Mouse anti-active β-catenin antibody was from Millipore. (Billerica, MA, USA); This antibody has been previously validated (5) . Lipofectamine® RNAiMAX Transfection Reagent was from ThermoFisher Scientific.
(Waltham, MA, USA); Wnt3a siRNA (antisense strand: 5'-GCAUCCGCUCUGACACUUAAUACTC-3'), negative control siRNA and TYE 563 DS (Minneapolis, MN, USA); This antibody has been previously validated (6) . 
Methods
No in vivo experiments were conducted in this study.
Animals
Five month old male C57BL/6 mice from Jackson Laboratory were used for isolation of bone cells and isolation of intact muscles for ex vivo contractility studies, following humane euthanasia cervical dislocation. All animal procedures were performed according to an approved IACUC protocol at the University of Missouri-Kansas City (UMKC), and conformed to relevant federal guidelines. The UMKC animal facility is operated as a specific pathogen-free, AAALAC 
Ex vivo muscle contractility
Dissection and setup: Mice were humanely sacrificed and soleus muscles were carefully removed for contractility analysis, as previously reported (17) and following the Protocol of the ms; train duration, 500 ms). Optimal muscle length (L0) was determined by tetanic stimulations of 100 Hz at an interval of 1 minute. Equilibration: The intact muscles were allowed a 30 minutes equilibration period during which time they were stimulated with pairs of alternating high (100 Hz) and low (20 Hz) frequency pulse-trains administered with a periodicity of 1 minute. Utilization of the proposed paradigm of stimulation helps with the study of the relative contributions of the contractile proteins (100 Hz) and the SR (20 Hz) to contractile function (17) .
After equilibration and stabilization of submaximal and maximal forces, blank medium or MLO-Y4 CM was added to the control and test muscle, respectively and force was followed for 30 minutes after the addition of the media. Force normalization: Muscle force was reported as relative force (mN) and force normalized to muscle physiological cross sectional area (N/cm 2 ) as previously reported by our group (17) (18) (19) . Five animals and 10 muscles were used for final analyses.
Cell cultures and generation of conditioned medium (CM) from primary osteocytes (PO
CM), MLO-Y4 cells (MLO-Y4 CM), 2T3 cells (2T3 CM) and MC3T3-E1 (MC3T3-E1 CM)
Cell culture: C2C12 myoblasts were cultured following our own previously published protocols (3, 5, 6) . Briefly, cells were grown at 37°C in a controlled humidified 5% CO2 atmosphere in growth medium (GM), DMEM/high glucose +10% FBS (100U/mL P/S), and maintained at 40 -70% cell density. Under these conditions, myoblasts proliferate, but do not differentiate into myotubes. During myoblast proliferation, medium was changed every 48 hours. To induce differentiation of myoblasts into myotubes, when cells reached 75% confluence, the culture media were switched from GM to differentiation medium (DM), DMEM/high glucose + 2.5%
horse serum (HS) (100U/mL P/S), and DM was changed every 48 hours. Fully differentiated, functional, contracting myotubes were formed within 5-7days.
MLO-Y4, a murine long bone-derived osteocyte-like cell line (referred to hereafter as MLO-Y4 cells), were cultured as previously described (20) . Briefly, cells were seeded onto type I collagencoated plates and cultured in αMEM + 2.5% FBS + 2.5% CS (100U/mL P/S). Cells were maintained at ~60% confluence throughout the culture period.
2T3 osteoblast-like cells (referred to hereafter as 2T3 cells) were cultured as previously described (21) with a few modifications. Briefly, cells were cultured in αMEM + 10% FBS (100U/mL P/S). Cells were maintained at ~60% confluence throughout the culture period.
MC3T3-E1 preosteoblast cells (referred to hereafter as MC3T3-E1 cells) were cultured as previously described (22) . Briefly, cells were cultured in αMEM + 10% FBS (100U/mL P/S).
Cells were maintained at ~60% confluence throughout the culture period.
Generation of CMs from primary osteocytes (PO CM), MLO-Y4 cells (MLO-Y4 CM), 2T3 cells (2T3 CM) and MC3T3-E1 cells (MC3T3-E1 CM):
The method of isolation of primary osteocytes was described by Stern et al. (23, 24) , with minor modifications. Briefly, long bones were dissected and muscles were removed taking care not to remove the periosteum. Epiphyses were cut and bone marrow was then flushed out. The bones were cut into small pieces (1-2 mm 2 ) and incubated for 25 minutes in collagenase solution (300 units/mL) with constant shaking in an incubator at 37ºC and 5% CO2. Solution was then removed and centrifuged. Cells were then resuspended in 10% FBS containing αMEM and plated in collagen-coated plates (fraction 1-fibroblast-enriched). Bone chips were then subsequently incubated with fresh collagenase solution to obtain fractions 2 to 4 (osteoblast-enriched). Then bone chips were digested in alternating EDTA (5 mM) and collagenase solutions to obtain fractions 5 to 9 (osteocyteenriched). The remaining bone pieces were transferred into collagen-coated dishes and cells migrated from the bone pieces after 3-5 days of culture (fraction 10-bone particles). All of the cells obtained from fractions 5 to 9 that displayed an osteocyte-like morphology stained positive for the osteocyte marker E11/GP38. The osteocyte phenotype was further confirmed by a lack of staining for alkaline phosphatase and the absence of collagen1a1 expression. The osteocytes also expressed additional osteocyte-specific genes such as Sost and Mepe. To generate PO CM, cells of fractions 5 to 9 were cultured in 60 cm 2 collagen-coated plates with αMEM + 5 % FBS + 5 % CS (1,000 U/mL P/S) culture media, 3600 cells/cm 2 and allowed to attach and grow for 48 hours.
The medium was collected and centrifuged at 500 × g for 10 minutes. Conditioned medium (CM) was aliquoted and flash frozen in liquid nitrogen then stored at -80°C.
To prepare MLO-Y4 CM, 2T3 CM and MC3T3-E1 CM, MLO-Y4, 2T3 and MC3T3-E1 cells were plated in 10cm dishes, 5000 cells/cm 2 and allowed to attach and grow for 48 hours. The medium was collected and centrifuged at 500 × g for 10 minutes. Conditioned medium (CM) was aliquoted and flash frozen in liquid nitrogen then stored at -80°C. 
ELISA for WNT3a in PO CM and MLO-Y4 CM
WNT3a in PO CM and MLO-Y4 CM was detected by Wingless Type MMTV Integration Site
Family, Member 3A (WNT3A) ELISA Kit according to the manufacturer's protocol. Serum-free CM were collected from the cells that were cultured for twenty four hours, and 100 μl CM was added into the ELISA plate wells coated with a biotin-conjugated WNT3a antibody. Next, Avidin conjugated to Horseradish peroxidase is added and incubated for 1 hour. After TMB substrate solution is added, the color change is measured spectrophotometrically at 450 nm. The concentration of WNT3a is then determined by comparing the O.D. of the samples to the standard curve. Three independent experiments with 2 replicates were performed for these experiments.
Immunolabeling of active β-catenin for nuclear translocation
These studies followed our previous protocols (25) with minor modifications for C2C12 cells.
Briefly, C2C12 cells were seeded onto positively-charged glass slides and cultured overnight.
CMs or blank media was added to produce 10% final concentration. Cells were incubated for 30 minutes, 60 minutes and 90 minutes respectively, rinsed two times in cold PBS, fixed in 2% paraformaldehyde containing 0.2% Triton X-100 for 10 minutes and then washed three times in PBS at ambient temperature for 10 minutes each. Slides were blocked with 2.5 % BSA and 1% normal donkey serum in PBS overnight at 4 °C. Primary antibody against the active form of β-catenin was used at 1:100 dilution in blocking buffer for 4 hours at ambient temperature. Slides were washed three times with PBS and incubated for 1 hour with Cy3 -conjugated donkey antimouse antibody. The quantification of the intensity of β-catenin immunofluorescence was performed as described previously using a Leica TCS SP5 II confocal microscopy system on an inverted microscope platform (26) . 16 bit images were obtained and were pseudo colored in green and analyzed using ImageJ Software (NIH). The nuclear and cytoplasmic histograms from each image were used to quantify staining intensity. Three independent experiments with 5-10 cells monitored on each individual experiments.
C2C12 Cell Morphometry and Immunostaining
Cell Morphology: Phase contrast images were taken with a LEICA DMI-4000B inverted microscope equipped with a 14-BIT CoolSNAP CCD camera (Photometrics), using the LEICA LAS imaging software for calibration (Leica microsystems).
Immunostaining: Experiments were performed following our published protocols (5, 6, 27) .
Briefly, C2C12 cells were fixed with neutral buffered formalin and permeabilized with 0.1%
Triton X-100. Myosin heavy chain (MHC) was detected with Anti-Human Myosin Heavy Chain-CFS (1:50) at room temperature for 30 minutes and counter stained with DAPI. Images were taken using a 20X LEICA FLUO objective with the LEICA system described above. Fusion index: To quantify myogenic differentiation of C2C12 cells after treatments, the Fusion Index (FI) was calculated, where FI is defined as: (nuclei within myosin heavy chain-expressing myotubes/total number of myogenic nuclei) × 100 (28) . We conducted 3-5 independent experiments, 2 replicates, and 3-5 areas per replicate were randomly selected for the measurements.
Treatment of C2C12 cells with PO CM, MLO-Y4 CM, 2T3 CM, MC3T3-E1 CM and
WNT3a
C2C12 cells were plated in 6-well plates, 10×10 4 /well, and allowed to attach and grow overnight.
Medium of C2C12 myoblasts were changed from GM to DM with CMs and WNT3a, respectively, 48 hours later, changed medium with fresh DM. CMs and WNT3a were removed from the medium. At day 3 of differentiation, C2C12 cells were analyzed according to "C2C12
Cell Morphometry and Immunostaining" described above. 
Treatment of MLO-Y4 cells with
Treatment of C2C12 cells with MLO-Y4 siRNA-treated CM
Medium of C2C12 myoblasts were changed from GM to DM with 10% CMs, respectively, 48
hours later, changed medium with fresh DM. CMs were removed from the medium. At day 3 of differentiation, C2C12 cells were analyzed according to "C2C12 Cell Morphometry and Immunostaining" described above.
Treatment of C2C12 cells with Sclerostin
a) C2C12 myoblasts in DM without Sclerostin treatment as a negative control. b) C2C12
myoblasts were treated with 100ng/mL Sclerostin in DM for 6 hours. c) C2C12 myoblasts were treated in DM with 10% MLO-Y4 CM for 48 hours as one of our positive controls. d) C2C12
myoblasts were treated in DM with 10ng/mL WNT3a for 48 hours as our second positive
control. e) C2C12 myoblasts were treated with 100ng/mL Sclerostin in DM for 6 hours, followed by 10% MLO-Y4 CM for 48 hours; f) C2C12 myoblasts were treated with 100ng/mL Sclerostin in DM for 6 hours, followed by 10ng/mLWNT3a for 48 hours; g) C2C12 myoblasts were treated with 100ng/mL Sclerostin in DM for 6 hours, followed by the combination of 10% MLO-Y4 CM + 10ng/mLWNT3a for 48 hours. Under any experimental where Sclerostin, CM, WNT3a was used, they were maintained during treatments for 48 hours. After 48 hours, medium was changed with fresh DM. Sclerostin, CM, and WNT3a were removed from the media. At day 3 of differentiation, C2C12 cells were analyzed according to "C2C12 Cell Morphometry and Immunostaining" described above.
RNA isolation and real time quantitative PCR (RT-qPCR)
Total RNA was isolated from the cells with Tri reagent according to the manufacturer's protocol and cDNA was synthesized using a high capacity cDNA reverse transcription kit. RT-qPCR was performed using RT 2 Real-Time TM SYBR green/Rox PCR master mix. RT-qPCR primers used in this study are summarized in Table 1 . RT-qPCR was run in a 25μl reaction volume on 96-well plates using a StepOnePlus instrument (Applied Biosystems, Foster city, CA, USA). Data were analyzed using RT² Profiler™ PCR Array Data Analysis (SABiosciences); Ct values were normalized to Gadph (Glyceraldehyde-3-phosphate dehydrogenase) as a reference gene. Gene expression was determined as fold up or down regulation of the gene of interest compared to the controls. All reactions were done in duplicate and all experiments were repeated at least three times.
RT-PCR Gene Arrays
The Mouse Signal Transduction PathwayFinder PCR Array from SABiosciences was used to simultaneously detect gene expression changes of 10 signaling pathways (see details in Table 2 ).
cDNA was synthesized using the RT² First Strand Kit (This kit contains genomic DNA elimination process) and the PCR Array was run according to the manufacturer's protocol including a threshold of 0.25 and validation of each gene tested by the identification of single peaks in melting curves. As above, data were analyzed using the RT² Profiler™ PCR Array Data Analysis Software; Ct values were normalized to six built-in reference housekeeping genes, genomic DNA control, reverse transcription control, and positive PCR control. We used this analytical software (http://www.qiagen.com/us/shop/genes-and-pathways/data-analysis-centeroverview-page/) to set the statistical significance of up/down regulation of all tested genes at 2-fold difference. Three independent experiments were performed.
Intracellular Ca 2+ measurements
A Photon Technology International (PTI) imaging system was used to measure intracellular calcium transients. The intracellular calcium transients produced by the stimulation of calcium release from sarcoplasmic reticulum (SR) with 20 mM caffeine were measured. Each myotube imaged was loaded with Fura-2, a ratiometric calcium dye and imaged in real time with the 14-BIT CoolSNAP CCD camera). All calcium imaging was analyzed with PTI EasyRatioPro fluorescence imaging software. We conduced 3-4 independent experiments, resulting in 12-18 cells analyzed per group (6) , (27) .
Statistical analysis
Data are presented as mean ± SD. Comparisons between more than two groups were made using one-way ANOVA followed by Tukey's post hoc test for multiple comparisons. Chain-CFS antibody which only stains maturing myocytes/myotubes not myoblasts and DAPI that stains only the nuclei (Fig. 1B) . We also detected the specific fusion index (FI) of each experimental group. These data are summarized in Fig. 1C , showing that FI is significantly increased in the treatment groups compared with control. When C2C12 cells were treated with the 10% CM deriving from two different osteoblast cell lines, 2T3 (an established osteoblast cell line) and MC3T3-E1 (a preosteoblast cell line), respectively, there is no significant effects on the myogenic differentiation ( Fig. 2A-B) . 
ELISA for WNT3a in PO CM and MLO-Y4 CM
The only commercially available ELISA kit was used to detect WNT3a in MLO-Y4 CM and PO CM and the factor was detected in the 100-200 pg/mL range. While this level might be considered low, we do see effects in vitro with WNT3a concentrations as low as 500 pg/mL.
Furthermore, there are many technical reasons that might explain these results, including the fact that it is technically challenging to isolate and purify WNT3A
(http://web.stanford.edu/group/nusselab/cgi-bin/wnt/purification).
Physiological concentrations of WNT3a and low concentrations of MLO-Y4 CM stimulate myogenesis of C2C12 cells
Studies were performed with concentrations of WNT3a ranging from 0.1 to 10ng/mL as well as 1% MLO-Y4 CM. A concentration as low as 0.5ng/mL to 10ng/mL WNT3a consistently enhanced the C2C12 cell differentiation (Fig. 4A and C) . In agreement with lower concentrations of WNT3a accelerating myogenesis, we also found that the myogenic differentiation of C2C12 cells was enhanced with as low as 1% MLO-Y4 CM. After 3 days of differentiation, a significant increase of the FI of MLO-Y4 CM-treated cells was found as compared with the control cells ( Fig. 4B and D) .
MLO-Y4 CM, PO CM, and WNT3a induced translocation of β-Catenin to the nucleus of
C2C12 cells
To explore the possible roles of Wnt/β-catenin pathway in C2C12 cells, confocal microscopy was used to study the time course of the subcellular localization of β-catenin after C2C12 cells were treated with 10% MLO-Y4 CM, which demonstrated that peak translocation occurred at 60 minutes (min) (Fig. 5A-B ). Next, we tested the effects of C2C12 growth medium (GM), C2C12 differentiation medium (DM), MLO-Y4 CM, PO CM, WNT3a and Lithium chloride as a positive control. The results demonstrated that β-catenin translocation to the nucleus was enhanced significantly by the different treatments when compared to GM. Furthermore, MLO-Y4 CM, PO CM, WNT3a and Lithium chloride treatments were more potent than DM in inducing nuclear translocation of β-catenin (Fig. 5C-D) .
Treatment of C2C12 cells with MLO-Y4 siRNA-treated CM
To explore the roles of WNT3a from MLO-Y4 CM on C2C12 cells, MLO-Y4 osteocytes were transfected with Wnt3a siRNA. To detect siRNA transfection efficiency, MLO-Y4 osteocytes were transfected with 10 nM TYE 563 DS Transfection Control siRNA. Twenty four hours after transfection, images were taken, and the percentage of fluorescent positive cells was determined.
The result revealed that the siRNA transfection efficiency of MLO-Y4 osteocytes was 80.02 ± 7.18% (Fig. 6A) . RT-qPCR was conducted to examine Wnt3a expression after knock down by 
Treatment of C2C12 cells with Sclerostin inhibits the effects of MLO-Y4 CM and WNT3a on myogenic differentiation.
Sclerostin is a Wnt signaling inhibitor (12) . To study the effect of Sclerostin on C2C12 myoblast differentiation stimulation by MLO-Y4 CM and WNT3a, C2C12 myoblasts were pre-treated with 100ng/mL Sclerostin for 6 hours prior to the addition of MLO-Y4 CM and WNT3a. At day 3 of differentiation, we measured the specific fusion index (FI) of each experimental group. FI data of each group is summarized in Fig. 7A-B, showing that compared to negative control (a), FI of treatment group (b): C2C12 myoblasts were treated with 100ng/mL Sclerostin in DM for 6 hours; treatment group (e): C2C12 myoblasts were treated with 100ng/mL Sclerostin in DM for 6 hours, followed by 10% MLO-Y4 CM for 48 hours; treatment group (f): C2C12 myoblasts were treated with 100ng/mL Sclerostin in DM for 6 hours, followed by 10ng/mLWNT3a for 48 hours was not significantly changed, and significantly reduced when compared to the positive controls (c and d), 10% MLO-Y4 CM and 10ng/mL WNT3a, respectively. The FI of treatment group (g): C2C12 myoblasts were treated with 100ng/mL Sclerostin in DM for 6 hours, followed by the combination of 10% MLO-Y4 CM + 10ng/mLWNT3a for 48 hours; increased significantly compared with negative control (DM), suggesting that only the MLO-Y4 CM + WNT3a together can overcome the inhibitory effect of Sclerostin.
Modulation of Gene Expression by MLO-Y4 CM and WNT3a
We employed the Mouse Signal Transduction PathwayFinder PCR Array to detect differences in expression of signaling molecules between control versus MLO-Y4 CM (10%) and WNT3a
(10ng/mL) treated C2C12 cells at 24 hours after treatment. A major advantage of this technology is that monitors 10 different pathways simultaneously and is validated at the protein level. We found a clear common shared gene regulation change in between 10% MLO-Y4 CM (Fig. 8A) and 10ng/mL WNT3a (Fig. 8B) , which was the upregulation of the Wnt pathway detected by the overexpression of Wnt1 in the cells treated with CM and Wnt5a and Axin2 in the cells treated with WNT3a.
We also employed RT-qPCR to detect the specific expression of myogenic differentiation markers (Mhc, MyoD and MyoG) and two Wnt/β-catenin downstream genes directly associated with C2C12 myogenesis (Fhl1 (29) , Numb (30) ). At day 3 of myotube differentiation, we found that This article is protected by copyright. All rights reserved both 1% and 10% MLO-Y4 CM, as well as 0.5ng and10ng/mL WNT3a (except Numb in 1%
MLO-Y4 CM) significantly increased the expression of these five specific genes ( Fig. 8C-D) .
MLO-Y4 CM and WNT3a enhance caffeine induced SR calcium release
Calcium homeostasis is very important in myoblast differentiation (31) , and is a major surrogate of skeletal muscle function (27) , (31) . Avila et al (32) have demonstrated that WNT3a modulates intracellular Ca 2+ in hippocampal neurons. Furthermore, since our ex vivo muscle contractility experiments showed that the force produced by the lower frequency of stimulation was increased, to determine if SR calcium release was influenced by either MLO-Y4 CM or WNT3a,
we employed an effective approach by testing the direct effects of caffeine's ability to release calcium from the SR in Fura-2 loaded myotubes. In day 5 of myotube differentiation, caffeine responses were significantly larger in myotubes treated with 10% MLO-Y4 CM and 10ng/mL WNT3a as indicated by multiple and oscillatory peaks and a prolongation of the relaxation phase of the calcium transient response induced by caffeine (Fig. 9A) .
MLO-Y4 CM and WNT3a induced common gene overexpression profile of
Ca 2+ signaling/hypertrophy, Ca 2+ homeostasis, mitochondrial biogenesis and oxidative
stress genes
Expression of important genes related to Ca 2+ signaling/hypertrophy, Ca 2+ homeostasis, mitochondrial biogenesis and oxidative stress in C2C12 cells at 60 hours of differentiation after treatments was detected by a focused custom-built RT-PCR gene array using the same technology that the PathwayFinder was used. In agreement with both the enhanced contractile force and SR calcium release by MLO-Y4 CM and WNT3a, the expression of these key regulatory pathways were significantly upregulated (Fig. 9B, and Table 3 ).
Discussion
Recent studies have shown that bone (osteoblasts and osteocytes) acts as an endocrine organ by the production and secretion of at least two circulating factors, FGF23 and osteocalcin (7) . Osteocytes also secreted large amounts of PGE2, which we previously demonstrated to be a promoter of C2C12 myoblasts myogenesis (3) and proliferation (33) .
Our concept is that bone-muscle crosstalk enhances myogenic differentiation but may also have effects on muscle function. In this study, we showed that 10% MLOY4 CM and 10%
BP CM enhanced C2C12 cell differentiation in vitro. In contrast, the differentiation was not significantly affected when C2C12 cells were treated with 10% 2T3 CM and 10% MC3T3-E1 CM, respectively. In support of this we found that 10% MLOY4 CM increased the force production of SOL muscles stimulated ex vivo at lower frequencies of stimulation, suggesting that osteocytes release soluble factors that can either promote increased calcium release from the sarcoplasmic reticulum (SR) or enhance the sensitivity of the contractile machinery to calcium.
Consistent with this, we showed that the caffeine-induced calcium release from the SR was significantly increased in C2C12 myotubes treated with MLO-Y4 CM and WNT3a. Another major motivation for the current study was the observation that WNT3a can activate MyoD and Myogenin (34) , and these two genes are important myogenic regulatory factors. WNT3a, that is found in the extracellular matrix of different cell types (35) , is expressed in C2C12 cells and 2T3 osteoblasts (36) (37) (38) , and is detected at relatively high levels in serum of both humans (16.9 ± 2.4ng/mL) and mice (0.225-3.74ng/mL) (39) , suggesting a potential role of WNT3a in bonemuscle crosstalk. In this study, we used RT-qRCR to detect Wnt3a expression after C2C12 myoblasts were treated with MLO-Y4 CM, and found that Wnt3a expression was not altered (data not shown). We detected WNT3a in ~200 pg/mL range in MLO-Y4 CM and PO CM CMs (40, 41) . These results might suggest that with increased levels of activity, bone-secreted WNT3a could increase, leading to signaling to muscle cells that modulate muscle function.
When C2C12 cells were treated with either 10% MLO-Y4 CM or PO CM, and 10ng/mL WNT3a, there was an enhancement of β-catenin translocation into the nucleus, providing evidence that the Wnt/β-catenin pathway is activated by CM and also by WNT3a. In contrast, when C2C12 cells were treated with either 10% 2T3 CM or 10% MC3T3-E1 CM (osteoblasts CMs), we did not observe any enhancement of myogenic differentiation, suggesting that factors secreted in the osteoblast CM are either different in nature or in concentration. This concept is further supported by the data from osteocytes showing that even 1% CM can enhance myogenic differentiation ( Fig. 4B and 4D ).
To directly test the involvement of WNT3a as a mediator of the effects of CM, we treated MLO-Y4 cell with Wnt3a siRNA and collected the CM (MLO-Y4 siRNA-treated CM) (Fig. 6) .
When C2C12 cells were treated with 10% MLO-Y4 siRNA-treated CM, there was no significant change of C2C12 cell differentiation. This indicated that WNT3a is a key factor in MLO-Y4 CM responsible for the enhancement effect of C2C12 cell differentiation.
Next, to further explore if Wnt/β-catenin pathway was involved in the effect of MLO-Y4
CM and WNT3a on C2C12 cell differentiation enhancement, we pre-treated C2C12 cells with Sclerostin which is a negative regulator of Wnt/β-catenin signaling pathway. Sclerostin inhibited the capacity of 10% MLO-Y4 CM and 10ng/mL WNT3a to enhance C2C12 cell differentiation, respectively, but failed to inhibit myogenic differentiation acceleration when CM and WNT3a
were combined in the same treatment. These results support that Wnt/β-catenin signaling pathway is involved in MLO-Y4 CM and WNT3a enhancement of C2C12 cell differentiation.
The reason that the combined treatment with MLO-Y4 CM and WNT3a together enhanced C2C12 cell differentiation may be because factors in MLO-Y4 CM (such as WNT3a, WNT1, et al) and WNT3a together reached a certain threshold that they competed with Sclerostin to bind to Lrp5 and Lrp6, then decrease the inhibition of Sclerostin on the Wnt/β-catenin signaling pathway. Furthermore, other factors in CM such as PGE2 could be contributing to the combined effects of CM and WNT3a.
To search for molecular insights into these effects of CM and WNT3a, we used the Mouse Signal Transduction PathwayFinder PCR Array and found that in 10% MLO-Y4 CM treatment, the expression of two protein coding genes Tnf and Wnt1 were significantly increased (Fig. 8A) . Tnf has been found to exert many of its effects on skeletal muscle through NFκB signaling (42) . It has been reported that mechanical stimulation of myoblasts leads to release of TNF, which is necessary for myogenic differentiation (43) . TNF is known to be one of the key regulators of skeletal muscle cell responses to injury. Whereas physiological levels of Tnf are transiently upregulated during myoblast regenerative responses to injury and stimulate differentiation, sustained high levels of TNF are associated with chronic inflammatory diseases and especially with muscle pathology associated with impairment of differentiation and muscle wasting. Wnt1 is directly involved in myogenesis (44) . Based on this, we propose that MLO-Y4
CM myogenic effect may be predominantly due to Tnf and Wnt1 activation. Since our data also
show that WNT1 can enhance myogenesis (Supplemental Fig. 1A-C) , the Wnt1 induced by MLOY4 CM might contribute to autocrine stimulation of the Wnt/β-catenin signaling pathway.
An important question raised by our experiments with CMs and WNT3a was whether other Wnts might exert similar effects. We tested this possibility by treating C2C12 myoblasts with WNT1 ranging from 0.5 to 100ng/mL. Interestingly, we found that the lower concentrations of WNT1 did not increase differentiation, but 10ng/mL, 50ng/mL and 100ng/mL of WNT1 significantly enhanced myogenic differentiation in C2C12 cells, although even at these higher concentrations WNT1 was less potent than WNT3a.
When C2C12 cells were treated with 10ng/mL WNT3a, the expression of two genes (Axin2, Wnt5a) increased significantly (Fig. 8B) . Axin2 associates directly with β-catenin, GSK-3β and APC (adenomatous polyposis coli) and is induced by active Wnt signaling and acts in a negative feedback loop (16) . Thus, upregulation of this gene indicates activation of the Wnt/β-catenin pathway. Wnt5a is involved in modulation of the non-canonical Wnt pathway, which regulates calcium inside cells (45) . Therefore, providing strong evidence that WNT3a is acting via Wnt/β-catenin pathway and mobilizing intracellular calcium.
In order to further confirm the enhancement of myogenic differentiation by both CM and WNT3a, we monitored with RT-qPCR the expression of two muscle regulatory factors (MRFs, MyoD and Myogenin) and one marker of terminal differentiation (Mhc) (Fig. 8C-D) . Our results showed upregulation of these genes. To further dissect the mechanisms underlying these effects, we also measured the expression of two Wnt/β-catenin pathway downstream genes (Fhl1, Numb), which were both upregulated. Fhl1 was recently shown to be a downstream gene of the Wnt signaling pathway that promotes differentiation of C2C12 cells (29) , and it has been reported that the expression of Numb was increased during C2C12 cell differentiation and that treatment with WNT3a increased both Numb gene and protein expressions (30) .
Therefore, although not exactly the same genes, CM and WNT3a seem to be activating the Wnt/β-catenin pathway and upregulation MRFs. In addition, striking similarities of overlapping gene regulation by MLO-Y4 CM and WNT3a were revealed by our custom-built muscle specific RT-PCR gene array as summarized in Fig. 9B . Our muscle specific -RT PCR gene array results allowed us to demonstrate that both CM and WNT3a upregulated genes associated to pathways linked to Ca 2+ signaling/hypertrophy, Ca 2+ homeostasis, mitochondrial biogenesis and oxidative stress ( Table 3 ). In support of our observations of enhanced force generation by SOL muscles induced by MLOY4 CM and increased myogenic differentiation and enhanced calcium released induced by both CM and WNT3a, we found overexpression of specific genes associated with SR calcium release (IP3Rs (46) (47) (48) and Fkbp1a (49, 50) ), SR calcium uptake (SERCAs (51) ), and store-operated calcium entry/myoblast differentiation (Stim 2) (52) .
These studies also revealed that three key Ca 2+ signaling genes (CamkII (53, 54) , Nfatc3 (52) and Srf (55) ) critical for myotube homeostasis and cellular hypertrophy were also upregulated as well as two genes associated with mitochondrial biogenesis and REDOX regulation (PGC1α (56) and SOD1 (57, 58) ). Our results are also in agreement with previous reports that suggested the maintenance of normal intracellular Ca 2+ concentration is vital to myocyte gene expression and differentiation (31) . It is also intriguing that Avila et al (32) has reported that WNT3a modulates intracellular Ca 2+ in hippocampal neurons, in fact, in a manner similar to that we have observed in muscle cells, suggesting that this might be a common mechanism in excitatory cells. We believe that the modulation in intracellular Ca 2+ might work as the biophysical linker between the molecular-genetic adaptations and the changes (phenotypes) induced by WNT3a in muscle cells.
A recurring question in this emerging field of bone-muscle crosstalk is how secreted factors from bone and muscle can reach each other. Experiments performed by Fritton and colleagues (59) show that mouse tail vein injection of small dyes and molecules up to 70 kDa can permeate the osteocyte-lacunar-canalicular network in just a few minutes, which is bigger than the size of both WNT3a and WNT1(~40kDa), and in fact the majority of WNTs. This demonstrates that the canalicular fluid has ready access to the circulation and suggests that factors secreted by osteocytes could enter the blood and have effects on distant target cells, including muscle. Furthermore, osteocytes are known to be the main producers of FGF23, which is readily detected in the serum, supporting an endocrine role for the osteocyte (reviewed in (7) ).
Another potential mechanism for the transport of factors between tissues is through microvesicles or extracellular vesicles (EVs), cell-derived membrane vesicles secreted by all cell types. The release of EVs is now recognized as an important modulator of crosstalk between many cells types, and in disease states (60) . Recently, McBride et al (61) demonstrated that bone marrow mesenchymal stem cell derived exosomes transport WNT3a and enhance dermal fibroblast proliferation and angiogenesis in vitro.
Conclusions
Obviously, a limitation of the current study is that we are not studying bone-muscle crosstalk in vivo, since this was beyond the scope of the current work. Importantly, the cell models and the ex vivo work did support the concept of bone to muscle signaling. In conclusion, our data showed Calibration bar =100 µm. 
